Led by Rosen, Artizan takes aim at inflammation
When James Rosen became president and CEO of Artizan Biosciences, it was a clear signal that Artizan was onto something big. Artizan’s initial product uses...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
When James Rosen became president and CEO of Artizan Biosciences, it was a clear signal that Artizan was onto something big. Artizan’s initial product uses...
UConn has hit an impressive new high in external research funding, with its faculty attracting more than $375 million in new awards in the past...
Boehringer Ingelheim reports the acquisition of Abexxa Biologics, a Texas biotech. “The acquisition of Abexxa bolsters our commitment to tumor-antigen discovery and new ways of...
When Connecticut state public health officials came calling at the start of the COVID-19 pandemic, Wren Laboratories was ready. With some new equipment and additional...
Several Connecticut colleges and universities made U.S. News and World Report’s annual list of best colleges. UConn again ranks among top 25 national public universities...
Sema4 has appointed Gustavo Stolovitzky, PhD, to the newly established senior leadership position of Chief Science Officer. Dr. Stolovitzky is a world-renowned expert in computational...
Pfizer and BioNTech have reported first results from a pivotal trial of a COVID-19 vaccine in children 5-11 years. The results show a favorable safety profile...
Astrocyte Pharmaceuticals reports it has received a $3.0M award from the Medical Technology Enterprise Consortium. The award will support the upcoming Phase 1 human safety...
Shelton’s NanoViricides has licensed, from West Haven’s TheraCour Pharma, a set of drugs that show promise against COVID-19. The licensed drugs include antiviral treatments for...
Jon Soderstrom is retiring, ending a 25-year run as Yale University’s head technology transfer expert. He led Yale’s efforts to boost its profile as a leader of global...